Found 13 matching trials
A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration
PHASE2Hereditary angioedema ("HAE") is a disease characterized by recurrent tissu...
Location
For information on sites, please contact Pharming Technologies
Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks
PHASE3This study is being conducted to confirm the efficacy, safety, and immunoge...
Location
Allergy, Asthma & Immunology, Assoc, Ltd.
RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function
PHASE1An unmet medical need exists for therapeutic regimens in transplantation th...
Location
University of Wisconsin
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
PHASE2Hereditary angioedema ("HAE") is a genetic disorder characterized by sudden...
Location
For information on sites please contact Pharming Medical Affairs Department
Patient Registry to Evaluate the Real-world Safety of Ruconest®
N/AThis is a prospective, real-world, observational patient registry for patie...
Location
The US Hereditary Angioedema Association
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
PHASE2The purpose of this multi-center study is to explore the efficacy, safety, ...
Location
For information on sites in Europe, please contact Pharming Technologies.
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
PHASE2The purpose of this single-center study is to explore the efficacy, safety,...
Location
For information contact Sonja Visscher
Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema
PHASE3Hereditary angioedema ("HAE") is a genetic disorder characterized by sudden...
Location
For information on sites, please contact Pharming Medical Affairs Deparment
Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation
PHASE2The purpose of this study will be to assess the safety, tolerability, and e...
Location
University of Wisconsin
A Phase 2 HAE Prophylaxis Study With Recombinant Human C1 Inhibitor
PHASE2Primary Objective:
To evaluate the efficacy of recombinant human C1 inhibi...
Location
University of South Florida Asthma, Allergy and Immunology Clinical Research Unit